CVS Caremark

The CVS Caremark team will be at the 70th Annual Employee Benefits Conference on November 10-13 in San Diego, CA. Stop by booth #607/609, and let’s talk about TrueCost, biosimilars and GLP-1s helping to lower overall costs with our integrated solutions and deliver better health outcomes. See you there!

Lowering premiums and out-of-pocket costs takes innovation and strategy, as Professor Anthony LoSasso explains in a recent Bloomberg Law. PBMs are driving these solutions, and we’re proud to do our part in making medications more affordable and accessible for our clients and their members. https://cvs.co/3AjXJuS

Most of us don’t like change. So, to increase the chances of success with biosimilar adoption we make it easy for providers and their patients, using proactive outreach to boost their confidence in the covered biosimilars, and ensure a frictionless transition. Listen to Emily Pefanis, PharmD, in the latest #AskCaremark segment.

We’ll be in Washington, DC, on November 6-8, 2024, as a sponsor of the 20th Annual Public Sector Healthcare Roundtable Conference and Business Meeting. Join us for in-depth conversations on “Looking to the Future: Public Sector Purchasers, Presidential Election, and the Evolving Washington Health Policy Environment.” If you’re attending, let's connect and discuss how these developments may impact the health care industry and your organization. We hope to see you there.

We make it easy for plan sponsors to keep up with the growing market for weight management drugs. When plan design includes coverage for GLP-1s, we’re focused on helping ensure appropriate utilization through intelligent controls. Check out our TrendLens spotlight on GLP-1s: https://cvs.co/4hfg4cZ #GLP1s #DrugTrend

Don't miss our latest Drugs to Watch Report. Learn more about the active drug pipeline, which includes three oncology drugs granted breakthrough therapy designations and and new drugs to expand RSV prevention. https://cvs.co/3Nym17i

Illnesses affect not only employees, but also their families, their ability to work, and the employers' bottom line. ?? Learn more about the importance of employee vaccination during flu season and year-round: https://cvs.co/4ffcM7F

Today, CVS Health appointed David Joyner as President and Chief Executive Officer. David was most recently Executive Vice President, CVS Health, and President, CVS Caremark. He brings to his new role 37 years of experience in the health care industry and pharmacy benefit management business. David said: “There is no greater honor than to lead a company whose mission and purpose are completely focused on improving health. I am proud to continue working side by side with our 300,000 colleagues who are building a world of health around every consumer, and we are committed to delivering our best every day to everyone we serve.” The company and the Board also recognize the many contributions of Karen Lynch during her time as President and CEO. Executive Chairman of the Board, Roger Farah said: “We are grateful for Karen’s consistent, customer-focused leadership, especially during the COVID-19 pandemic when our pharmacies provided needed tests and vaccines. We also appreciate her work to advance our company’s modernization and transformation to become a diversified, connected, technology-driven health care provider, allowing us to do even more for the people we are privileged to serve.”

Weight loss is a journey, and the CVS Weight Management program is here to help. With personalized support and nutrition, members like Melissa are seeing real, lasting results. The impact speaks for itself: ? 6x total weight loss for members who struggled with medication alone ? Nearly 90% member satisfaction

Accelerating adoption. Delivering significant client savings. Helping members save more with lower-cost alternatives. We’re committed to maximizing the potential of #biosimilars to bring down costs and improve access and affordability for everyone. Learn more at: https://cvs.co/4fprgST